tiprankstipranks
Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
US Market

Chromocell Therapeutics Corp (CHRO) Financial Statements

7 Followers

Chromocell Therapeutics Corp Financial Overview

Chromocell Therapeutics Corp's market cap is currently ―. The company's EPS TTM is $-1.543; its P/E ratio is -1.13; Chromocell Therapeutics Corp is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders$ -1.42M$ -953.35K$ -966.56K$ -739.59K-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 22.79K$ 81.89K$ 48.61K$ 55.07K$ 173.24K
Total Assets$ 22.79K$ 81.89K$ 48.61K$ 55.07K$ 44.46M
Total Debt$ 631.01K$ 540.16K$ 450.00K$ 435.63K$ 397.82K
Net Debt$ 608.22K$ 458.26K$ 401.39K$ 380.56K$ 224.58K
Total Liabilities$ 5.93M$ 4.98M$ 4.45M$ 3.76M$ 3.18M
Stockholders Equity$ -5.90M$ -4.90M$ -4.40M$ -3.71M$ 41.28M
Cash Flow-
Free Cash Flow$ -257.24K-$ -173.37K$ -666.62K-
Operating Cash Flow$ -257.24K-$ -173.37K$ -666.62K-
Investing Cash Flow-----
Financing Cash Flow$ 198.13K-$ 166.90K$ 548.45K-
Currency in USD

Chromocell Therapeutics Corp Earnings and Revenue History

Chromocell Therapeutics Corp Debt to Assets

Chromocell Therapeutics Corp Cash Flow

Chromocell Therapeutics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis